We are live on ! Find out more
ACG

Anchorage Capital Group Portfolio holdings

AUM $436M
1-Year Est. Return 38.51%
This Fund
S&P 500
This Quarter Est. Return
-1.56%
1 Year Est. Return
-38.51%
3 Year Est. Return
-18.86%
5 Year Est. Return
-55.07%
10 Year Est. Return
+90.94%
AUM
$3.86B
AUM Growth
+$2.59B
Cap. Flow
+$2.22B
Cap. Flow %
57.37%
Top 10 Hldgs %
96.03%
Holding
33
New
10
Increased
1
Reduced
3
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 20.6%
2 Communication Services 6.05%
3 Energy 1.02%
4 Consumer Discretionary 0.68%
5 Technology 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$1.72B 44.45%
4,000,000
+3,500,000
+700% +$1.54B
DNA icon
2
Ginkgo Bioworks
DNA
$517M
$778M 20.15%
+1,678,784
New +$817M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$547M 14.16%
+2,500,000
New +$554M
FYBR
4
DELISTED
Frontier Communications
FYBR
$199M 5.15%
7,129,824
-236,743
-3% -$7.05M
CNSL
5
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$35M 0.91%
3,812,892
GDP
6
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$30.8M 0.8%
1,300,000
-269,878
-17% -$4.73M
AMBP icon
7
Ardagh Metal Packaging
AMBP
$2.8B
$24.9M 0.64%
+2,500,000
New +$27.3M
CRWD icon
8
PUT
CrowdStrike
CRWD
$207B
$21M 0.54%
+342,000
New +$22.1M
ZY
9
DELISTED
Zymergen Inc. Common Stock
ZY
$15.3M 0.4%
+1,161,188
New +$24.6M
KPLT icon
10
Katapult Holdings
KPLT
$32.8M
$14.3M 0.37%
105,035
EXE
11
Expand Energy Corp
EXE
$21.1B
$8.7M 0.23%
141,239
-132,972
-48% -$7.46M
ACT icon
12
Enact Holdings
ACT
$6.49B
$2.19M 0.06%
+100,000
New +$2.12M
AMBP.WS
13
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$2.01M 0.05%
+935,651
New +$2.07M
OCDX
14
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$1.85M 0.05%
+100,000
New +$2.01M
ARD
15
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$1.26M 0.03%
+49,428
New +$1.24M
DNA.WS
16
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$170K ﹤0.01%
+50,000
New +$178K
AMC icon
17
PUT
AMC Entertainment Holdings
AMC
$1.73B
-400,000
Closed -$227M
BB icon
18
PUT
BlackBerry
BB
$5.27B
-1,000,000
Closed -$12.2M
GME icon
19
PUT
GameStop
GME
$9.82B
-400,000
Closed -$21.4M
MVIS icon
20
PUT
Microvision
MVIS
$104M
-500,000
Closed -$8.38M
LUXE
21
LuxExperience B.V.
LUXE
$1.12B
-27,603
Closed -$840K
S icon
22
SentinelOne
S
$6.71B
-700,000
Closed -$29.8M
BBBY
23
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
-500,000
Closed -$16.6M
SRNGU
24
DELISTED
Soaring Eagle Acquisition Corp. Unit
SRNGU
-250,000
Closed -$2.65M
GRSV
25
DELISTED
Gores Holdings V, Inc.
GRSV
-2,500,000
Closed -$25.3M

Similar funds

Anchorage Capital Group's Q3 2021 Portfolio in Review

As of Q3 2021, Anchorage Capital Group held 33 positions worth $3.86B, up 204% from $1.27B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Anchorage Capital Group deployed $2.22B of net new capital in Q3 2021, opening 10 new positions and adding to 1 existing holding. Its largest new stake was Ginkgo Bioworks: 1,678,784 shares worth $778M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 0% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Expand Energy Corp, an estimated $7.46M trimmed.

  • Anchorage Capital Group's largest Q3 2021 buy was Ginkgo Bioworks: 1,678,784 shares worth $778M.
  • Anchorage Capital Group's biggest Q3 2021 reduction was Expand Energy Corp, cutting an estimated $7.46M.
  • Anchorage Capital Group fully exited SentinelOne in Q3 2021, selling an estimated $29.8M.
  • Anchorage Capital Group's ten largest holdings make up 96% of its $3.86B portfolio in Q3 2021.
  • Anchorage Capital Group opened 10 new positions and closed 10 in Q3 2021.
  • Anchorage Capital Group's portfolio value rose 204% quarter-over-quarter to $3.86B.

Based on Anchorage Capital Group's 13F filing for Q3 2021, filed 15 Nov 2021.